news

Our latest
Press Releases & Updates

Latest press releases

Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

Ikerian has secured USD 8M (CHF 6.73M) in the first close of its Series B round, led by Sanoptis, to enhance its AI-driven RetinAI Discovery platform and expand into new therapeutic areas.

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

RetinAI partners with MAXO and TFS HealthScience to support two pivotal dry eye disease studies.

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing

NVIDIA GTC Europe 2018 [OCTOBER’18]

RetinAI was one of the 10 startup to present on the NVIDIA GTC Europe Inception Awards 2018. Hundreds of applications, 70 teams in the pitching semi-finals and only 10 teams in the final. What a great opportunity to show the world how Artificial Intelligence is going to change the standard of eye care in 2019.

‍

Venture Leaders China 2018 [SEPTEMBER'18]

The 10-day business roadshow in China with VentureLab is only a week away! Get to know the Venture Leaders China team member Carlos Ciller, CEO & co-founder of RetinAI before the trip begins! Source: VentureLab.

Welcome to the new RetinAI [SEPTEMBER'18]

There's nothing permanent except change - Heraclitus. We are incredibly pleased to announce our new logo at RetinAI! This new image reflects our values, strengths and willingness to connect the anatomical and digital worlds to provide a better healthcare for the patient.

RetinAI on the Top100 Swiss Startups [SEPTEMBER’18]

This year RetinAI has been selected as one of the TOP 100 of Swiss Startups 2018! It’s a great recognition for the team. We are proud of the results we are achieving and we are extremely excited about the future ahead!

Our latest
Press Releases & Updates

Latest press releases

Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing

Latest updates

NVIDIA GTC Europe 2018 [OCTOBER’18]

Venture Leaders China 2018 [SEPTEMBER'18]

Welcome to the new RetinAI [SEPTEMBER'18]

RetinAI on the Top100 Swiss Startups [SEPTEMBER’18]

Contact us for more informations! We are happy to hear from you!

Sign Up And Receive Our Latest Promotions!

Our latest Press Releases & Updates

Latest press releases

Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing

Latest updates

NVIDIA GTC Europe 2018 [OCTOBER’18]

Venture Leaders China 2018 [SEPTEMBER'18]

Welcome to the new RetinAI [SEPTEMBER'18]

RetinAI on the Top100 Swiss Startups [SEPTEMBER’18]

Contact us for more informations! We are happy to hear from you!

Our latest
Press Releases & Updates